Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Botox Treatment for Migraine and Chronic Daily Headache in Adolescents
Journal of Neuroscience Nursing, 10/27/09
Chan VW et al. – The authors treated 12 adolescents (aged 14 to 18 years) with Botox injections for migraine and chronic daily headache. Six patients were in long–term treatment and received Botox in the standard "migraine" and "follow–the–pain" patterns every 3 months. Effectiveness was evaluated using pain scales and a standardized quality–of–life survey at baseline and prior to each treatment session. Duration of treatment was 3–29 months. Each patient had 9–63 injections per treatment. All 6 long–term patients reported improvement in headache symptoms, with decreases on pain scales and an average of 33%–75% improvement in quality of life. Two long–term patients had complete relief of headaches between injection series. Four patients had only one series of injections with good results. Two patients had no improvement and refused additional injections. Side effects were mild ptosis, blurred vision, hematoma at neck injection site with tingling in one arm lasting 24 hours, and burning sensations at all injection sites which lasted 1 week.
Related Articles
Tension-Type Headache in Children: The Cinderella of Headache Disorders!
Canadian Journal of Neurological Sciences, 10/26/09
Relevance Score: 94%
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study
Acta Neurologica Scandinavica, 10/06/09
Relevance Score: 93%
Migraine type childhood headache aggravated by sexual abuse: case report
Agri, 10/12/09
Relevance Score: 92%
Botulinum toxin in the treatment of lingual movement disorders
Movement Disorders, 10/06/09
Relevance Score: 90%
Evaluation of Variable-Dose Treatment with a New U.S. Botulinum Toxin Type A (Dysport) for Correction of Moderate to Severe Glabellar Lines: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Plastic and Reconstructive Surgery, 11/13/09
Relevance Score: 89%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Cross Talk: A New Method for Peripheral Nerve Stimulation. An Observational Report with Cadaveric Verification
Pain Physician, 11/25/09
Ultrasound-Guided Cryoablation of Genitofemoral Nerve for Chronic Inguinal Pain
Pain Physician, 11/25/09
Evidence-Based Medicine, Systematic Reviews, and Guidelines in Interventional Pain Management: Part 7: Systematic Reviews and Meta-Analyses of Diagnostic Accuracy Studies
Pain Physician, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


